Skip to content
Home/Companies/HealthTech/Cellese

Cellese

HealthTech·United States·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Cellese?

Cellese is an American HealthTech company, currently owned by ARCHIMED since 2024.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
ARCHIMED
Investor
ARCHIMED
MED Rise · 2024 · Buyout

Key facts

HQUnited States
SectorHealthTech

More from MED Rise

Other portfolio companies in the same fund.

IRAB
IRAB
Active
PharmaSpain· 2026
Renata Medical
Active
MedTechUnited States· 2026
Agatha
Active
HealthTechJapan· 2025
Arkstone
Active
HealthTechUS· 2025
Ceva
Ceva
Active
PharmaFrance· 2025
Ceva Animal Health
Ceva Animal Health
Active
PharmaFrance· 2025

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Cellese?

Cellese is currently owned by ARCHIMED, through MED Rise, since 2024.

When did ARCHIMED acquire Cellese?

ARCHIMED acquired Cellese in 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue